Catalyst Wire Dossier Catalyst Wire Dossier

BR3409

· Boryung Pharmaceutical Co., Ltd
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for BR3409, covering 2025-03-17 to 2025-03-17. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Pharmacokinetics and Safety of BR3409 and Co-administration of BR3409-1 and BR3409-2 in Healthy Volunteers Under Fed Conditions [Phase 1]

See pricing